Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||||
| Cash from operating activities | 2.59M | 1.76M | 7.61M | -1.23M | 185.11%3.6M | -67.78%1.26M | 3.92M |
| Net profit before non-cash adjustment | --1.49M | --633K | --6.66M | ---1.29M | 28.13%7.06M | 35.98%5.51M | --4.05M |
| Total adjustment of non-cash items | --460K | ---47K | ---229.18K | --46K | -1,912.10%-177.47K | 61.17%-8.82K | ---22.71K |
| -Depreciation and amortization | --28K | --28K | --135.45K | --108K | 1.78%62.19K | 12.03%61.1K | --54.54K |
| -Disposal profit | --0 | ---22K | ---- | ---- | --0 | --0 | --1.03K |
| -Other non-cash items | --432K | ---53K | ---364.63K | ---62K | -242.74%-239.66K | 10.68%-69.92K | ---78.28K |
| Changes in working capital | --642K | --1.17M | --1.17M | --7K | 22.56%-3.28M | -3,754.86%-4.24M | ---109.99K |
| -Change in receivables | ---- | ---- | --337.24K | --619K | -281.85%-162.3K | -61.85%89.25K | --233.95K |
| -Change in inventory | ---264K | --2.51M | --325.16K | ---1.21M | 17.65%-2.97M | -389.56%-3.61M | ---737.88K |
| -Change in prepaid assets | --992K | ---1.4M | --299.88K | --448K | 82.68%-135.68K | -292.37%-783.49K | --407.29K |
| -Change in payables | ---5K | --64K | --210.25K | --145K | -115.44%-10.31K | 600.19%66.77K | ---13.35K |
| Dividends paid (cash flow from operating activities) | |||||||
| Dividends received (cash flow from operating activities) | |||||||
| Interest paid (cash flow from operating activities) | |||||||
| Interest received (cash flow from operating activities) | -432K | 53K | 364.63K | 62K | 242.74%239.66K | 10.74%69.92K | 63.15K |
| Tax refund paid | -340K | -340K | -2.5M | -415K | -153.50%-1.85M | 49.39%-728.33K | -1.44M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | --1.82M | --1.47M | --5.47M | ---1.59M | 229.84%1.99M | -76.23%604.73K | --2.54M |
| Investing cash flow | |||||||
| Net PPE purchase and sale | ---15K | --17K | ---241.17K | ---86K | -127.58%-15.06K | 97.45%-6.62K | ---259.62K |
| Net investment product transactions | ---1M | ---1.3M | ---15M | ---15M | --0 | --0 | --250K |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | ---- | --0 | --0 | --15.96K |
| Investing cash flow | ---1.02M | ---1.28M | ---15.24M | ---15.09M | -127.58%-15.06K | -204.37%-6.62K | --6.34K |
| Financing cash flow | |||||||
| Net common stock issuance | ---- | ---- | --12.85M | --12.85M | --2K | --0 | --0 |
| Increase or decrease of lease financing | ---- | ---- | ---- | ---- | --0 | --0 | ---34.76K |
| Cash dividends paid | ---- | ---- | ---1.01M | ---1.01M | -16.67%-1.4M | 40.00%-1.2M | ---2M |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | ---- | --0 | --0 | ---820 |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | -201.50%-42.01K | --41.39K |
| Financing cash flow | ---- | ---- | --11.83M | --11.84M | -12.56%-1.4M | 37.72%-1.24M | ---1.99M |
| Net cash flow | |||||||
| Beginning cash position | --6.99M | --6.8M | --4.73M | --11.63M | -13.43%4.15M | 13.14%4.79M | --4.24M |
| Current changes in cash | --801K | --188K | --2.07M | ---4.84M | 190.33%581.61K | -215.66%-643.9K | --556.73K |
| End cash Position | --7.79M | --6.99M | --6.8M | --6.8M | 14.02%4.73M | -13.43%4.15M | --4.79M |
| Free cash flow | --1.8M | --1.47M | --5.23M | ---1.67M | 230.98%1.98M | -73.82%598.11K | --2.28M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.